In Vitro Fertilization (IVF) Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

In vitro fertilization is the technique of assisted reproduction, where male sperm and female egg is fertilized by placing together in a plastic dish or cell culture. The fertilized egg is implanted in the uterus to make an effort to attach and develop the egg inside the female body. The egg, embryos, or sperms are preserved, frozen, and are stored for later use. In 1978, the first IVF baby, Louise Brown was born in the United Kingdom. The in vitro fertilization technique was primarily developed to treat infertility caused by damaged or blocked of fallopian tubes, but now it is used to treat a wide range of infertility problems. 

The global in vitro fertilization (IVF) market is segmented as product type, cycle type, and by geography. Based on product type, the in vitro fertilization (IVF) market is segmented into instruments and reagent & media. The instruments segment is further sub-segmented into cryosystem, incubators, imaging system, ovum aspiration pump, cabinet, micromanipulator system, sperm separation system, disposables and accessories, and other instruments. The reagent & media segment is again segmented into cryopreservation media, ovum processing media, semen processing media, and embryo culture media. On the basis of cycle type, the in vitro fertilization (IVF) market is segmented into fresh donor IVF cycles, fresh non-donor IVF cycles, frozen donor IVF cycles, and frozen non-donor IVF cycles. 

Asia Pacific held a dominant share of the global market for in vitro fertilization (IVF) in the 2017 and is projected to continue with its regional supremacy over the forthcoming years as well. The increasing availability and accessibility of healthcare facilities, growing research and development expenditure, increasing infertility rate, rising prevalence of PCOS, and continuous growth in fertility tourism is expected to propel the growth of in vitro fertilization (IVF) market in the Asia Pacific. Followed by the Asia Pacific is Europe which anticipates holding the second largest share of the global market. The high awareness about the in vitro fertilization (IVF) products, ease of reimbursement policies, and easy availability of in vitro fertilization (IVF) products in the region are significantly contributing towards the growth of the market in Europe. 

Some of the key players in the in vitro fertilization (IVF) market are Cooper Surgical, Inc., Thermo Fisher Scientific, Vitrolife, Cook, Irvine Scientific, EMD Serono, Inc., Genea Limited, Esco Group, Rocket Medical plc, Nidacon International AB, Lotus Bio, Eppendorf AG, Okolab Srl, IKS International, Hunter Scientific Limited, Labotect GmbH, Olympus Corporation, and RI.MOS. Srl.